Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China
贝达喹啉、利奈唑胺、左氧氟沙星、氯法齐明和环丝氨酸联合化疗9个月治疗利福平/多重耐药结核病:一项在中国开展的多中心、随机、开放标签非劣效性试验
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-024-03633-3
Song, Yanhua; Shu, Wei; Pei, Yi; Du, Juan; Wu, Guihui; Wang, Hua; Mi, Fengling; Liu, Fangchao; Ma, Liping; Xie, Li; Kong, Zhongshun; Wu, Xiaoguang; Liu, Rongmei; Chen, Hongmei; Li, Hua; Ge, Qiping; Nie, Lihui; Lv, Zizheng; Huang, Xuerui; Li, Mingwu; Jiang, Mingying; Chen, Xiaohong; Cai, Qingshan; Chen, Wei; Liu, Yanmei; Miao, Yanfang; Tang, Yan; Chen, Yu; Geng, Shujun; Zhou, Quanying; Liu, Yuhong; Pang, Yu; Gao, Mengqiu